Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Potential utility of rituximab for Graves' orbitopathy.

Salvi M, Vannucchi G, Beck-Peccoz P.

J Clin Endocrinol Metab. 2013 Nov;98(11):4291-9. doi: 10.1210/jc.2013-1804. Epub 2013 Sep 5.

PMID:
24009135
[PubMed - indexed for MEDLINE]
2.

Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.

Vannucchi G, Campi I, Bonomi M, Covelli D, Dazzi D, Currò N, Simonetta S, Bonara P, Persani L, Guastella C, Wall J, Beck-Peccoz P, Salvi M.

Clin Exp Immunol. 2010 Sep;161(3):436-43. doi: 10.1111/j.1365-2249.2010.04191.x.

PMID:
20529087
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

New immunomodulators in the treatment of Graves' ophthalmopathy.

Salvi M, Vannucchi G, Campi I, Currò N, Beck-Peccoz P.

Ann Endocrinol (Paris). 2008 Apr;69(2):153-6. doi: 10.1016/j.ando.2008.02.013. Epub 2008 Apr 15.

PMID:
18417090
[PubMed - indexed for MEDLINE]
4.

Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.

Salvi M, Vannucchi G, Campi I, Rossi S, Bonara P, Sbrozzi F, Guastella C, Avignone S, Pirola G, Ratiglia R, Beck-Peccoz P.

Eur J Endocrinol. 2006 Apr;154(4):511-7.

PMID:
16556712
[PubMed - indexed for MEDLINE]
Free Article
5.

The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy.

Mitchell AL, Gan EH, Morris M, Johnson K, Neoh C, Dickinson AJ, Perros P, Pearce SH.

Clin Endocrinol (Oxf). 2013 Sep;79(3):437-42. doi: 10.1111/cen.12141. Epub 2013 May 11.

PMID:
23320840
[PubMed - indexed for MEDLINE]
6.

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Hegedüs L, Smith TJ, Douglas RS, Nielsen CH.

Clin Endocrinol (Oxf). 2011 Jan;74(1):1-8. doi: 10.1111/j.1365-2265.2010.03806.x. Review.

PMID:
20455896
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.

Vannucchi G, Covelli D, Currò N, Dazzi D, Maffini A, Campi I, Bonara P, Guastella C, Pignataro L, Ratiglia R, Beck-Peccoz P, Salvi M.

J Clin Endocrinol Metab. 2012 May;97(5):E755-9. doi: 10.1210/jc.2011-2614. Epub 2012 Mar 7.

PMID:
22399512
[PubMed - indexed for MEDLINE]
8.

Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.

Salvi M, Vannucchi G, Campi I, Currò N, Dazzi D, Simonetta S, Bonara P, Rossi S, Sina C, Guastella C, Ratiglia R, Beck-Peccoz P.

Eur J Endocrinol. 2007 Jan;156(1):33-40.

PMID:
17218723
[PubMed - indexed for MEDLINE]
Free Article
9.

Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for Graves' ophthalmopathy.

Bonara P, Vannucchi G, Campi I, Rossi S, Cantoni F, Frugoni C, Sbrozzi F, Guastella C, Avignone S, Beck-Peccoz P, Salvi M.

Clin Rev Allergy Immunol. 2008 Feb;34(1):118-23. doi: 10.1007/s12016-007-8024-3.

PMID:
18270865
[PubMed - indexed for MEDLINE]
10.

B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.

El Fassi D, Nielsen CH, Bonnema SJ, Hasselbalch HC, Hegedüs L.

J Clin Endocrinol Metab. 2007 May;92(5):1769-72. Epub 2007 Feb 6.

PMID:
17284622
[PubMed - indexed for MEDLINE]
11.

B-cell targeted therapy with rituximab for thyroid eye disease: closer to the clinic.

Shen S, Chan A, Sfikakis PP, Hsiu Ling AL, Detorakis ET, Boboridis KG, Mavrikakis I.

Surv Ophthalmol. 2013 May-Jun;58(3):252-65. doi: 10.1016/j.survophthal.2012.10.006. Epub 2012 Dec 17. Review.

PMID:
23253433
[PubMed - indexed for MEDLINE]
12.

B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.

Nielsen CH, El Fassi D, Hasselbalch HC, Bendtzen K, Hegedüs L.

Expert Opin Biol Ther. 2007 Jul;7(7):1061-78. Review.

PMID:
17665994
[PubMed - indexed for MEDLINE]
13.

[New immunomodulators in treatment of Graves'ophtalmopathy].

Josseaume C, Lorcy Y.

Ann Endocrinol (Paris). 2008 Sep;69 Suppl 1:S29-32. doi: 10.1016/S0003-4266(08)73965-9. French.

PMID:
18954856
[PubMed - indexed for MEDLINE]
14.

Novel treatment modalities for Graves' orbitopathy.

Bartalena L, Lai A, Sassi L, Lombardi V, Dalle Mule I, Gandolfo M, Liparulo L, Azzolini C, Piantanida E, Tanda ML.

Pediatr Endocrinol Rev. 2010 Mar;7 Suppl 2:210-6. Review.

PMID:
20467365
[PubMed - indexed for MEDLINE]
15.

Rituximab in the treatment of thyroid eye disease: science fiction?

Salvi M, Vannucchi G, Campi I, Beck-Peccoz P.

Orbit. 2009;28(4):251-5.

PMID:
19839884
[PubMed - indexed for MEDLINE]
16.

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.

Khanna D, Chong KK, Afifiyan NF, Hwang CJ, Lee DK, Garneau HC, Goldberg RA, Darwin CH, Smith TJ, Douglas RS.

Ophthalmology. 2010 Jan;117(1):133-139.e2. doi: 10.1016/j.ophtha.2009.05.029. Epub 2009 Oct 8.

PMID:
19818507
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Orbital B-lymphocyte depletion in a treatment failure of rituximab for thyroid eye disease.

Gess AJ, Silkiss RZ.

Ophthal Plast Reconstr Surg. 2014 Jan-Feb;30(1):e11-3. doi: 10.1097/IOP.0b013e31828956a8.

PMID:
23531951
[PubMed - indexed for MEDLINE]
18.

Rituximab for thyroid-associated ophthalmopathy.

Minakaran N, Ezra DG.

Cochrane Database Syst Rev. 2013 May 31;5:CD009226. doi: 10.1002/14651858.CD009226.pub2. Review.

PMID:
23728689
[PubMed - indexed for MEDLINE]
19.

[Novel treatment of Graves' disease using the B-lymphocyte depleting agent rituximab].

Nielsen CH, El Fassi D, Hegedüs L.

Ugeskr Laeger. 2008 Jun 9;170(24):2131-4. Danish.

PMID:
18565295
[PubMed - indexed for MEDLINE]
20.

[Biological treatment options for Graves' ophthalmopathy].

El Fassi D, Nielsen CH, Hegedüs L.

Ugeskr Laeger. 2008 Jun 9;170(24):2128-30. Danish.

PMID:
18565294
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk